Clinical Trial Update: Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID) [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial evaluating elsiglutide to prevent chemotherapy-induced diarrhea in colorectal cancer patients receiving 5-FU-based chemotherapy; tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Diarrhea
• Colorectal Cancer

Drugs mentioned

• Elsiglutide (elsiglutide)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Drug and/or Toxin-induced Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2024-03-01